The outlook of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key markets has introduced considerable volatility. Investors are now assessing the effect of rival medications , reduc